E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation

被引:0
|
作者
L Sun
J S Trausch-Azar
A Ciechanover
A L Schwartz
机构
[1] Washington University School of Medicine and St Louis Children's Hospital,Edward Mallinckrodt Department of Pediatrics
[2] Washington University School of Medicine and St Louis Children's Hospital,Department of Molecular Biology and Pharmacology
[3] Vascular and Tumor Biology Research Center,undefined
[4] Faculty of Medicine,undefined
[5] Technion-Israel Institute for Technology,undefined
来源
Oncogene | 2007年 / 26卷
关键词
E2A; E12; E47; ubiquitin; proteasome; muscle differentiation;
D O I
暂无
中图分类号
学科分类号
摘要
The E2A proteins are basic helix–loop–helix transcription factors that regulate proliferation and differentiation in many cell types. In muscle cells, the E2A proteins form heterodimers with muscle regulatory factors such as MyoD, which then bind to DNA and regulate the transcription of target genes essential for muscle differentiation. We now demonstrate that E2A proteins are primarily localized in the nucleus in both C2C12 myoblasts and myotubes, and are degraded by the ubiquitin proteasome system evidenced by stabilization following treatment with the proteasome inhibitor, MG132. During the differentiation from myoblast to myotube, the cellular abundance of E2A proteins is relatively unaltered, despite significant changes (each ∼5-fold) in the relative rates of protein synthesis and protein degradation via the ubiquitin-proteasome system. The rate of ubiquitin-proteasome-mediated E2A protein degradation depends on the myogenic differentiation state (t½∼2 h in proliferating myoblasts versus t½>10 h in differentiated myotubes), and is also associated with cell cycle in non-muscle cells. Our findings reveal an important role for both translational and post-translational regulatory mechanisms in mediating the complex program of muscle differentiation determined by the E2A proteins.
引用
收藏
页码:441 / 448
页数:7
相关论文
共 50 条
  • [1] E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation
    Sun, L.
    Trausch-Azar, J. S.
    Ciechanover, A.
    Schwartz, A. L.
    ONCOGENE, 2007, 26 (03) : 441 - 448
  • [2] Protein degradation: Hijacking the ubiquitin-proteasome system
    Shanmugasundaram, Veerabahu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [3] Immunologic aspects of protein degradation by the ubiquitin-proteasome system
    Reinstein, E
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (07): : 420 - 424
  • [4] Ubiquitin-proteasome pathway of intracellular protein degradation: Implications for muscle atrophy during unloading
    Demartino, GN
    Ordway, GA
    EXERCISE AND SPORT SCIENCES REVIEWS, VOLUME 28, 1998, 1998, 26 : 219 - 252
  • [5] The Ubiquitin-Proteasome System and Memory: Moving Beyond Protein Degradation
    Jarome, Timothy J.
    Devulapalli, Rishi K.
    NEUROSCIENTIST, 2018, 24 (06): : 639 - 651
  • [6] Ubiquitin-Proteasome System-Regulated Protein Degradation in Spermatogenesis
    Xiong, Yi
    Yu, Chao
    Zhang, Qianting
    CELLS, 2022, 11 (06)
  • [7] Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats
    Qiyi Chen
    Ning Li
    Weiming Zhu
    Weiqin Li
    Shaoqiu Tang
    Wenkui Yu
    Tao Gao
    Juanjuan Zhang
    Jieshou Li
    Journal of Inflammation, 8
  • [8] Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats
    Chen, Qiyi
    Li, Ning
    Zhu, Weiming
    Li, Weiqin
    Tang, Shaoqiu
    Yu, Wenkui
    Gao, Tao
    Zhang, Juanjuan
    Li, Jieshou
    JOURNAL OF INFLAMMATION-LONDON, 2011, 8
  • [9] Cigarette Smoke Induces Akt Protein Degradation by the Ubiquitin-Proteasome System
    Kim, Sun-Yong
    Lee, Ji-Hyun
    Huh, Jin Won
    Ro, Jai Youl
    Oh, Yeon-Mock
    Lee, Sang-Do
    An, Sungkwan
    Lee, Yun-Song
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (37) : 31932 - 31943
  • [10] E2F-1 degradation by the ubiquitin-proteasome pathway
    Hofmann, F
    Livingston, DM
    GENOMIC INSTABILITY AND IMMORTALITY IN CANCER, 1997, 8 : 215 - 227